Example logo GIS 26

Global Innovation Summit 2026

6 May 2026 | Basel, Switzerland

Home
Register
Register
Register

Dimitra Stergiopoulou

Senior IVD Development and Technology Transfer Officer/ Responsible for Regulatory Compliance

Oncolipsy

Athens, Greece

My organisation

Oncolipsy

Oncolipsy

other

Athens, Greece

Oncolipsy is a cutting-edge product line offering market-ready, blood-based molecular diagnostic kits designed for oncological applications. Pharmassist’s R&D department is dedicated to the development and commercialization of innovative molecular in vitro diagnostic products for the oncology field. Since 2014, the company has focused its efforts on developing CE-IVD PCR kits, establishing a clear strategy for securing proprietary assets through patents and trademarks. To date, Pharmassist has successfully acquired nine granted patents through PCT and national applications in major markets, including Europe, the USA, Canada, Israel, India, China, Japan, and Hong Kong. The company has developed two novel molecular diagnostic kits currently available on the market. These PCR-based tests, certified with CE-IVD, are designed to detect cancer-related biomarkers in both peripheral blood and tumor samples from cancer patients. These diagnostic kits have been developed and manufactured at Pharmassist’s privately owned facilities, which adhere to the highest quality standards. The facilities are certified according to ISO 13485, ISO 9001, and GMP requirements, ensuring the reliability and excellence of the products.
Read more

About me

I am a chemist with a PhD specializing in the development, validation, and performance evaluation of analytical methods for detecting clinically relevant biomarkers in liquid biopsy samples. I have extensive experience in molecular diagnostics, circulating tumor cell (CTC) and circulating tumor DNA (ctDNA) analysis, and assay optimization for oncology applications.

For the past five years, I have been with Pharmassist, contributing to molecular IVD development, diagnostic innovation, and regulatory strategy. I currently serve as Senior IVD Development and Technology Transfer Officer and act as Responsible for Regulatory Compliance.

Beyond my industry role, I am a Board Member of the Hellenic Liquid Biopsy Society, fostering scientific collaboration and advancement in the field.

In B2B meetings, I am particularly focused on exploring partnerships with diagnostic laboratories, healthcare providers, and industry collaborators, offering innovative diagnostic solutions.